• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    0.28 Up 0.00(0.11%) Feb 12, 3:57PM EST
    Prev Close:0.28
    Open:0.30
    Bid:0.28 x 400
    Ask:0.32 x 3600
    1y Target Est:3.00
    Beta:1.69989
    Earnings Date:Mar 28 - Apr 1 (Est.)
    Day's Range:0.28 - 0.30
    52wk Range:0.27 - 1.73
    Volume:168,273
    Avg Vol (3m):399,584
    Market Cap:18.32M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIUp 0.11%18.32M
    AGNUp 2.16%110.57B
    ALNYUp 4.55%5.05B
    MRNAUp 2.86%4.87M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):381.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.22
    Quarterly EPS Est (Dec-15) :-0.05
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback